首页> 外国专利> pharmaceutical preparations.the influence demaagzuurafscheiding possess at least a qu anidinothiazoolderivaat bevattenalsmede as active substance for use in such preparations suitable quanidinothiazoopolyacrylic.

pharmaceutical preparations.the influence demaagzuurafscheiding possess at least a qu anidinothiazoolderivaat bevattenalsmede as active substance for use in such preparations suitable quanidinothiazoopolyacrylic.

机译:药物制剂。影响脱mazuzuurafscheiding具有至少一种qu anidinothiazoazoereratat bevattenalsmede作为活性物质,适用于这种制剂中的quanidinothiazoopolyacrylic。

摘要

Novel guanidinothiazole compounds of the general formula IMAGE wherein R represents a hydrogen atom or a lower alkyl group, R1 represents an amino group, a lower alkyl group, a halogeno lower alkyl group, a substituted- or unsubstituted-aryl group, a mono- or di-lower alkylamino group, an arylamino group or an aralkylamino group, R2 represents a hydrogen atom, a lower alkyl group, a lower alkenyl group or a lower alkynyl group, Y represents a sulfur atom or a methylene group, m and n, each represents an integer of 1-3, and the pharmacologically acceptable acid addition salts thereof, they are useful as gastric acid secretion inhibitors.
机译:通式的新型胍基二唑化合物,其中R表示氢原子或低级烷基,R1表示氨基,低级烷基,卤代低级烷基,取代或未取代的芳基,单-或二低级烷基氨基,芳基氨基或芳烷基氨基,R 2表示氢原子,低级烷基,低级烯基或低级炔基,Y表示硫原子或亚甲基,m和n ,各自代表1-3的整数,及其药理学上可接受的酸加成盐,它们可用作胃酸分泌抑制剂。

著录项

  • 公开/公告号NL930038I2

    专利类型

  • 公开/公告日1993-10-01

    原文格式PDF

  • 申请/专利权人 YAMANOUCHI PHARMACEUTICAL CO. LTD.;

    申请/专利号NL19930930038C

  • 发明设计人

    申请日1993-05-19

  • 分类号C07D277/20;A61K31/425;A61K31/426;A61P1;A61P1/04;A61P43;C07D277/40;C07D277/48;

  • 国家 NL

  • 入库时间 2022-08-22 05:11:00

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号